CompletedNot Applicable

Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer

United States17 participantsStarted 2019-04-17

Plain-language summary

This randomized study examines how well zinc works in improving quality of life in patients with gastrointestinal cancer that cannot be removed by surgery who are receiving chemotherapy. Zinc may help to improve patient's quality of life by preventing zinc deficiency.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who present to adult medical oncology outpatient clinic with new diagnosis of non-resectable gastric, gastro-esophageal, pancreas or biliary cancer * Patients plan to receive chemotherapy at an Emory Cancer Center * No prior chemotherapy or radiation therapy for newly diagnosed gastric, gastro-esophageal, pancreas or biliary cancer * Patients must sign informed consent Exclusion Criteria: * Zinc supplementation is not indicated for pregnant or lactating women therefore, this is an exclusion criteria and women of childbearing age will complete a pregnancy test

What they're measuring

Quality of life scores

Timeframe: Up to 4 months after study start

Trial details

NCT IDNCT03819088

SponsorEmory University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-10-05

View on ClinicalTrials.gov More Gastric Carcinoma trials